The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021

Kento Kawai; Ann M. Stowe; Conor L. Evans; Ruxandra F. Sîrbulescu; Dusan Hanidziar; Kang Mi Lee; Thomas F. Tedder; Mark C. Poznansky

doi:10.1096/fj.202100963

The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021

Kento Kawai, Ann M. Stowe, Conor L. Evans, Ruxandra F. Sîrbulescu, Dusan Hanidziar, Kang Mi Lee, Thomas F. Tedder, Mark C. Poznansky

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e21744
Journal	FASEB Journal
Volume	35
Issue number	8
DOIs	https://doi.org/10.1096/fj.202100963
State	Published - Aug 2021

Bibliographical note

Funding Information:
M. C. Poznansky is the scientific founder of B‐Genesys. R. F. Sîrbulescu is a member of the scientific advisory board of B‐Genesys. T. F. Tedder is the founder, holds shares in, and receives funding from Cellective BioTherapy Inc

Funding Information:
The work presented by A. M. Stowe was supported by the American Heart Association (14SDG18410020), the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS; NS088555), and the Dana Foundation David Mahoney Neuroimaging Program. The work presented by C. L. Evans was supported by the US Department of Defense/Military Medical Photonics Program (FA9550‐16‐1‐0479). The work presented by R. F. Sîrbulescu was supported by the Massachusetts General Hospital Vaccine and Immunotherapy Center (VIC) Innovation Fund; the Trinity Innovation Fund, Holy Cross Hospital, Ft. Lauderdale, FFL, USA; and The Ward Family Fund for Regenerative Medicine at VIC. The work presented by D. Hanidziar is supported by a Clinical Investigator Award (K08HL141694) from the NIH/National Heart, Lung, and Blood Institute (NHLBI).

Funding

M. C. Poznansky is the scientific founder of B‐Genesys. R. F. Sîrbulescu is a member of the scientific advisory board of B‐Genesys. T. F. Tedder is the founder, holds shares in, and receives funding from Cellective BioTherapy Inc The work presented by A. M. Stowe was supported by the American Heart Association (14SDG18410020), the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS; NS088555), and the Dana Foundation David Mahoney Neuroimaging Program. The work presented by C. L. Evans was supported by the US Department of Defense/Military Medical Photonics Program (FA9550‐16‐1‐0479). The work presented by R. F. Sîrbulescu was supported by the Massachusetts General Hospital Vaccine and Immunotherapy Center (VIC) Innovation Fund; the Trinity Innovation Fund, Holy Cross Hospital, Ft. Lauderdale, FFL, USA; and The Ward Family Fund for Regenerative Medicine at VIC. The work presented by D. Hanidziar is supported by a Clinical Investigator Award (K08HL141694) from the NIH/National Heart, Lung, and Blood Institute (NHLBI).

Funders	Funder number
Cellective BioTherapy Inc
Massachusetts General Hospital Vaccine and Immunotherapy Center
Trinity Innovation Fund
US Department of Defense/Military Medical Photonics Program	FA9550‐16‐1‐0479
New Vic Theatre
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute Family Blood Pressure Program	K08HL141694
National Heart, Lung, and Blood Institute Family Blood Pressure Program
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council	R01NS088555
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council
American the American Heart Association	14SDG18410020
American the American Heart Association
Charles A Dana Foundation

ASJC Scopus subject areas

Biotechnology
Biochemistry
Molecular Biology
Genetics

Access to Document

10.1096/fj.202100963

Cite this

@article{5f286bdec7194d4b9983042e7b063799,

title = "The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021",

author = "Kento Kawai and Stowe, \{Ann M.\} and Evans, \{Conor L.\} and S{\^i}rbulescu, \{Ruxandra F.\} and Dusan Hanidziar and Lee, \{Kang Mi\} and Tedder, \{Thomas F.\} and Poznansky, \{Mark C.\}",

note = "Funding Information: M. C. Poznansky is the scientific founder of B‐Genesys. R. F. S{\^i}rbulescu is a member of the scientific advisory board of B‐Genesys. T. F. Tedder is the founder, holds shares in, and receives funding from Cellective BioTherapy Inc Funding Information: The work presented by A. M. Stowe was supported by the American Heart Association (14SDG18410020), the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS; NS088555), and the Dana Foundation David Mahoney Neuroimaging Program. The work presented by C. L. Evans was supported by the US Department of Defense/Military Medical Photonics Program (FA9550‐16‐1‐0479). The work presented by R. F. S{\^i}rbulescu was supported by the Massachusetts General Hospital Vaccine and Immunotherapy Center (VIC) Innovation Fund; the Trinity Innovation Fund, Holy Cross Hospital, Ft. Lauderdale, FFL, USA; and The Ward Family Fund for Regenerative Medicine at VIC. The work presented by D. Hanidziar is supported by a Clinical Investigator Award (K08HL141694) from the NIH/National Heart, Lung, and Blood Institute (NHLBI). ",

year = "2021",

month = aug,

doi = "10.1096/fj.202100963",

language = "English",

volume = "35",

number = "8",

}

TY - JOUR

T1 - The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021

AU - Kawai, Kento

AU - Stowe, Ann M.

AU - Evans, Conor L.

AU - Sîrbulescu, Ruxandra F.

AU - Hanidziar, Dusan

AU - Lee, Kang Mi

AU - Tedder, Thomas F.

AU - Poznansky, Mark C.

N1 - Funding Information: M. C. Poznansky is the scientific founder of B‐Genesys. R. F. Sîrbulescu is a member of the scientific advisory board of B‐Genesys. T. F. Tedder is the founder, holds shares in, and receives funding from Cellective BioTherapy Inc Funding Information: The work presented by A. M. Stowe was supported by the American Heart Association (14SDG18410020), the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS; NS088555), and the Dana Foundation David Mahoney Neuroimaging Program. The work presented by C. L. Evans was supported by the US Department of Defense/Military Medical Photonics Program (FA9550‐16‐1‐0479). The work presented by R. F. Sîrbulescu was supported by the Massachusetts General Hospital Vaccine and Immunotherapy Center (VIC) Innovation Fund; the Trinity Innovation Fund, Holy Cross Hospital, Ft. Lauderdale, FFL, USA; and The Ward Family Fund for Regenerative Medicine at VIC. The work presented by D. Hanidziar is supported by a Clinical Investigator Award (K08HL141694) from the NIH/National Heart, Lung, and Blood Institute (NHLBI).

PY - 2021/8

Y1 - 2021/8

UR - https://www.scopus.com/pages/publications/85110793196

UR - https://www.scopus.com/inward/citedby.url?scp=85110793196&partnerID=8YFLogxK

U2 - 10.1096/fj.202100963

DO - 10.1096/fj.202100963

M3 - Article

C2 - 34224602

AN - SCOPUS:85110793196

SN - 0892-6638

VL - 35

JO - FASEB Journal

JF - FASEB Journal

IS - 8

M1 - e21744

ER -

The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021

Bibliographical note

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this